Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Artificial cytokine storm combined with hyperthermia induces significant anti-tumor effect in mice inoculated with lewis lung carcinoma and B16 melanoma cells
Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ
Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma
[Immune response of heparinase gene modified dendritic cell-based vaccine on gastric cancer cells]
Antigen-independent immune responses after dendritic cell vaccination
Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival
[Successful immunotherapy combined with hyperthermia therapy for cancer patients]
Dendritic cell vaccination in patients with malignant gliomas: current status and future directions
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
Recent advances in immunotherapy for human glioma
A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia
Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma
Hyperthermia and immunity. A brief overview
Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic cells
In vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients
Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells
Vaccination therapy in prostate cancer
Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses
[Clinical impact of locoregional hyperthermia in gynecological oncology]
Current status of immunotherapy in B cell malignancies